Volunteers sought for coronavirus vaccine study launching at Halton Hospital VOLUNTEERS from Halton and Warrington are being asked to sign up to a new study which could see a new coronavirus vaccine approved for use across the country. The National Institute for Health Research-supported Valneva study will be run at Halton Hospital’s clinical research unit and is open to healthy adults who have not previously had a Covid-19 vaccine. Across the UK, 4,000 participants will be recruited for the study, which will see each participant receive two active vaccine doses administered in a four-week interval. Those enrolled in the study over the age of 30 will be randomised to receive two doses of either the Valneva vaccine or the approved Oxford-AstraZeneca vaccine.
Warrington Guardian Lockdown Heroes awards - last chance to enter warringtonguardian.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from warringtonguardian.co.uk Daily Mail and Mail on Sunday newspapers.
Warrington and Halton Hospitals CEO Professor Simon Constable and chairman Steve McGuirk officially open the new Clinical Research Unit at Halton Hospital A FUTURE coronavirus vaccine could be approved for use in the UK thanks to the contribution of Warrington residents. This is thanks to the opening of a new, dedicated facility for clinical research and trials at Halton Hospital. Halton Clinical Research Unit, within the Nightingale Building on the Runcorn site, will provide opportunities for people in Halton, Warrington, Cheshire and Merseyside to participate in clinical trials and research close to home. The unit has already received approval for its first clinical trial due to start next month, which is for a new Covid-19 vaccine candidate.
Boss of Grenfell contractor was warned about cladding after Bucharest fire in 2009 but did nothing dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.